VOLUME 14 | NUMBER 10 | OCTOBER 2011 nature neurOSCIenCe a r t I C l e S A key feature of Parkinson's disease is the progressive demise of mesencephalic dopaminergic (mDA) neurons in the substantia nigra pars compacta (SNpc). The molecular mechanisms leading to mDA cell loss are not entirely clear. However, several studies indicate that mitochondrial complex I impairment is central to this pathology [1] [2] [3] . In recent years, several transcription factors involved in mDA cell development have been identified 4 . Some of them remain expressed throughout life, including the homeoproteins Engrailed-1 (En1) and Engrailed-2 (En2) 5 , but their adult functions are poorly understood.
a r t I C l e S
A key feature of Parkinson's disease is the progressive demise of mesencephalic dopaminergic (mDA) neurons in the substantia nigra pars compacta (SNpc). The molecular mechanisms leading to mDA cell loss are not entirely clear. However, several studies indicate that mitochondrial complex I impairment is central to this pathology [1] [2] [3] . In recent years, several transcription factors involved in mDA cell development have been identified 4 . Some of them remain expressed throughout life, including the homeoproteins Engrailed-1 (En1) and Engrailed-2 (En2) 5 , but their adult functions are poorly understood.
We explored the function of En1 and En2 (Engrailed) in the survival of adult mDA cells. The two proteins are equivalent in the midbrain 6 , and mice heterozygous for En1 (En1 +/− En2 +/+ ) display a gradual loss of mDA neurons in the SNpc and ventral tegmental area (VTA) 7 . This loss is more severe in the SNpc than in the VTA, a phenotype reminiscent of Parkinson's disease, and mutant mice show behavioral (including motor) deficits. Notably, the infusion of Engrailed into the SNpc arrests adult mDA neuronal loss in En1 +/− En2 +/+ mice 7 . Engrailed, like many other homeoproteins, is internalized by live cells, gaining access to their cytoplasm and nucleus 8 .
This study investigated whether exogenously applied Engrailed protein is neuroprotective against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolite MPP + (1-methyl-4-phenylpyridinium), a classical toxin-based Parkinson's disease model, and sought to better understand the neuroprotection mechanisms. Engrailed, although a transcription factor, also regulates mRNA translation 9, 10 . This regulation, first observed in growth cones, probably engages the mTOR (mammalian target of rapamycin) pathway, as it is accompanied by the phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) and eIF4E binding protein 1 (4E-BP1), two key regulators of protein translation 11 . Regulating translation may be a property of several homeoproteins, because many of them, including Engrailed, bind eIF4E 12, 13 .
We thus examined whether Engrailed survival activity involves translational targets. In the case of mDA neurons, this hypothesis is supported by the presence of En1 protein in dendrites, where no transcription takes place 14 . We found that Engrailed regulates the translation of Ndufs1 and Ndufs3, two mitochondrial complex I proteins, and that this regulation participates in mDA neuron protection against cell death induced by complex I-specific neurotoxins. This protection by Engrailed extended to the 6-hydroxydopamine (6-OHDA) and α-synuclein-A30P Parkinson's disease models 15, 16 . In addition, we found that Engrailed infused in the midbrain of unlesioned mice increased striatal dopamine and induced associated motor activity, suggesting a physiological function for a homeoprotein transcription factor in the adult brain.
RESULTS
Engrailed protects mDA neurons against complex I toxins As a first in vitro approach to examine whether Engrailed protected mDA neurons in experimental Parkinson's disease models, we dissociated Mice heterozygous for the homeobox gene Engrailed-1 (En1) display progressive loss of mesencephalic dopaminergic (mDA) neurons. We report that exogenous Engrailed-1 and Engrailed-2 (collectively Engrailed) protect mDA neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mitochondrial complex I toxin used to model Parkinson's disease in animals. Engrailed enhances the translation of nuclearly encoded mRNAs for two key complex I subunits, Ndufs1 and Ndufs3, and increases complex I activity. Accordingly, in vivo protection against MPTP by Engrailed is antagonized by Ndufs1 small interfering RNA. An association between Engrailed and complex I is further confirmed by the reduced expression of Ndufs1 and Ndufs3 in the substantia nigra pars compacta of En1 heterozygous mice. Engrailed also confers in vivo protection against 6-hydroxydopamine and a-synuclein-A30P. Finally, the unilateral infusion of Engrailed into the midbrain increases striatal dopamine content, resulting in contralateral amphetamine-induced turning. Therefore, Engrailed is both a survival factor for adult mDA neurons and a regulator of their physiological activity. a r t I C l e S embryonic ventral midbrain cells at embryonic day (E) 14.5 and cultured for 3 d before the addition of MPP + (3 µM) for 2 d, with or without Engrailed. Ten days after plating, the number of tyrosine hydroxylase-labeled neurons was 2,003 ± 110 in control cultures and the number in the presence of MPP + was 85% lower (86.73% ± 1.75%, mean ± s.e.m.). En1 and En2 doubled mDA cell survival (Fig. 1a) , with a dose-dependent protection and a maximal effect between 0.3 and 3 nM (Fig. 1b) . EnSR, an En2 internalization-deficient mutant 9 had no effect on mDA cell survival (Fig. 1a) , indicating that survival activity requires internalization. The number of cells positive for NeuN (a neuron-specific nuclear protein) remained unaffected in all conditions (Fig. 1c) . MPP + is selectively captured by the dopamine transporter (DAT), explaining the specific loss of mDA neurons. We therefore verified that Engrailed does not protect mDA cells by decreasing DAT activity (Supplementary Fig. 1 ). Under these culture conditions, about 80% of the cells were neurons (Supplementary Fig. 2 ).
Because Engrailed is expressed in most embryonic midbrain neurons in culture, we examined its protective effect against rotenone, a complex I inhibitor not selective for mDA neurons 17 . Rotenone (50 nM) killed 37.8% ± 5.5% of tyrosine hydroxylase-positive (Fig. 1d) and 18.0% ± 2.9% (Fig. 1e) of NeuN-positive neurons. Engrailed alone was without effect on the number of NeuN-and mDA cells, but it fully protected the two populations of neurons against rotenone (Fig. 1d,e) . In contrast, Engrailed was not effective against 3-nitropropionic acid (3-NP), a complex II toxin. The numbers of tyrosine hydroxylase-and NeuN-positive cells were reduced by 3-NP (by 36.6% ± 1.9% and 28.8% ± 1.9%, respectively), with no protection by Engrailed (Fig. 1f,g ). Engrailed therefore protects embryonic midbrain neurons against complex I but not complex II toxins.
Engrailed enhances the translation of complex I subunits Given that internalized Engrailed regulates translation in growth cones 9,10 , we hypothesized that local mRNA translation in response to Engrailed internalization may participate in its protective effect. In a first approach, we treated adult midbrain synaptoneurosomes a r t I C l e S (a fraction enriched in synaptic terminals) with En1 (15 nM) or vehicle for 1 h at 37 °C in the presence of 35 S-methionine and 35 S-cysteine and identified newly synthesized En1-regulated proteins by mass spectrometry. Among 26 proteins identified, 16 were localized to mitochondria, including Ndufs1, a key subunit of mitochondrial complex I. Most mitochondrial proteins are encoded by nuclear genes and translated from mRNAs surrounding the organelle 18 . To further investigate Engrailed activity on local translation of complex I proteins, complex I was immunoprecipitated from Engrailed-or vehicle-treated radiolabeled synaptoneurosomes. Of seven protein species verified by mass spectroscopy, Engrailed increased the synthesis of Ndufs1 (+43%) and Ndufs3 (+68%) (Fig. 2a,b) , two key proteins for complex I turnover and activity 19, 20 . Immunoprecipitation of complexes II and V revealed no obvious changes after Engrailed treatment (Supplementary Fig. 3 ). Finally, complex I, but not complex IV, activity was increased by 20% in Engrailed-treated synaptoneurosomes, an increase reflected at the level of mitochondrial metabolism measured by citrate synthase activity (Fig. 2c) .
Accordingly, Engrailed (3 nM for 4 h) increased Ndufs1 and Ndufs3 (169% ± 16% and 363% ± 25%, respectively; Fig. 3a,b) in midbrain cultures. The greater change in cells compared to synaptoneurosomes could reflect the fact that all midbrain embryonic neurons express Engrailed, whereas synaptoneurosomes are heterogeneous. These increases were not observed in the presence of antibodies to Engrailed (anti-Engrailed), indicating that Engrailed is the active entity. Ndufs1 and Ndufs3 increases were maintained in the presence of the transcription inhibitor actinomycin D (5 µg ml −1 ) and thus do not depend on transcriptional activity (Fig. 3a,b) . Of note, Engrailed did not alter the levels of cyclooxygenase IV (Cox IV), a component of complex IV of the respiratory chain (Fig. 3c) .
To further verify that Ndufs1 and Ndufs3 are part of an Engrailedregulated pathway, we quantified their expression in the SNpc of 1-yearold En1 +/− En2 +/+ mice and their wild-type (WT) littermates. Ndufs1 and Ndufs3 immunoreactivity in mDA neurons were significantly lower in the SNpc of En1 +/− En2 +/+ mice (25.39% ± 5.76% and 24.05% ± 7.26%, respectively, P < 0.05; n = 4 mice per group) (Fig. 4a,b) . No change of expression was observed for Cox IV (Fig. 4b) . Ndufs3 expression showed no change in the oculomotor nucleus (Fig. 4b) , a mesencephalic structure where Engrailed is not expressed. Nor were there any changes in the VTA (Supplementary Fig. 4) . Finally, double immunofluorescence confirmed a 21.26% ± 3.3% (P < 0.01, n = 4 En1 +/− En2 +/+ and n = 4 WT littermates) decrease in Ndufs3 expression specifically in tyrosine hydroxylase-expressing neurons from En1 +/− En2 +/+ mice (Fig. 4c,d ). All in all, these results demonstrate that Engrailed regulates the local translation of mitochondrial complex I proteins during development and in the adult. a r t I C l e S (i.p.) daily on days 5 to 9 (Fig. 5a) . In these conditions, Engrailed diffuses into the SNpc and VTA and is internalized by most neurons in the region 7 . Engrailed or sham infusion had no effect on the number of tyrosine hydroxylase-positive cells in mice treated i.p. with saline. The number of mDA cells in the SNpc of uninfused (contralateral) side, shaminfused and Engrailed-infused sides of mice treated i.p. with saline was 5,687 ± 33 (Fig. 5b) . In MPTP-administered mice, the number of tyrosine hydroxylase-positive neurons was 32% ± 3.1% lower (P < 0.01). Infusion of Engrailed partially protected against MPTP, as the number of tyrosine hydroxylase-positive cells was lower by only 15.6% ± 3.3% (48.7% protection) (Fig. 5c) , comparing Engrailedinfused side to the uninfused side (same mouse) or to both sides of sham-infused mice (P < 0.01) (Fig. 5d) . The number of tyrosine hydroxylase-negative neurons per side ranged from 1,780 ± 194 to 1,970 ± 170 and did not differ significantly among the conditions (Nissl staining, Supplementary Fig. 5) . Therefore, the higher number of tyrosine hydroxylase-positive cells in Engrailed-infused tissues reflects cell survival and not an upregulation of tyrosine hydroxylase expression.
To test whether Ndufs1 upregulation is necessary for Engrailedmediated mDA neuron protection, we infused together with Engrailed a cell-permeable, Penetratin-coupled small interfering RNA (siRNA) 21 against Ndufs1, and administered systemic MPTP. Penetratin is a cellpenetrating peptide used to transport cargoes into live cells 22 . We first determined conditions in which downregulation of Ndufs1 expression by the siRNA is significant (P < 0.05) but moderate enough not to jeopardize cell survival (Supplementary Fig. 6 ). MPTP decreased the number of tyrosine hydroxylase-positive neurons by 36% ± 3.7% (Fig. 5c) , and Engrailed (with a control siRNA) limited cell death to 27% ± 4.04% (Fig. 5e) , a protective effect fully abolished by an siRNA directed against Ndufs1 (Fig. 5e) . These data confirm that Ndufs1 translation is part of the Engrailed neuroprotection pathway.
Engrailed increases striatal dopamine in vivo
To examine the functional consequences of Engrailed-mediated protection of mDA neurons, we measured striatal dopamine in Engrailedor sham-infused mice injected i.p. with MPTP or saline. As expected, striatal dopamine levels were lower in both ipsi-and contralateral sides in sham-infused, MPTP-injected mice as compared to shaminfused, saline-injected controls, reflecting mDA cell loss (Fig. 6a) . In contrast, ipsilateral striatal dopamine content in Engrailed-infused mice injected with MPTP remained in the range of that found in sham-infused, saline-injected controls. Thus, Engrailed protected against MPTP-induced striatal dopamine decrease.
Dopamine levels in the Engrailed-infused side of MPTP-injected mice were higher (>100% of control) than expected given a protection of 50% of mDA neurons, suggesting that Engrailed not only provided neuroprotection, but also directly enhanced dopamine synthesis. To test this hypothesis, we measured dopamine in the striatum of Engrailed-infused mice injected with saline. Whereas the number of mDA cells in the SNpc did not change (Fig. 5c) , dopamine levels were increased by more than 50% (Fig. 6a) .
This increase in striatal dopamine thus reflects both more surviving mDA neurons (in MPTP-treated mice) and a higher dopamine content per terminal (in MPTP-and in saline-injected mice). We thus used dopamine content to further analyze the role of complex I in Engrailed activity. MPTP alone reduced striatal dopamine by 80 to 90% (Fig. 6b) ; Engrailed infused in the presence of a control siRNA rescued dopamine content to 35% of control values, whereas Ndufs1 siRNA fully antagonized this rescue. This confirmed that (Fig. 6c) . MPTP-injected mice infused with Ndufs1 siRNA or saline-injected mice infused with control siRNA did not respond to amphetamine treatment by contralateral turning (−2.37 ± 0.96 net turns per minute and −1.04 ± 0.88 net turns per minute, respectively). Because siRNAs at the concentration used for these experiments had no effect of their own on dopamine levels or turning behavior (Fig. 6b,c) , we conclude that Engrailedinduced mDA survival, dopamine synthesis and turning involve an increase in Ndufs1 expression.
Given that Engrailed infusion into the SNpc of control mice markedly increases striatal dopamine, we tested the effect of Engrailed on turning behavior. Engrailed-infused mice turned preferentially contralateral to the side of infusion (−3.79 ± 0.58 net turns per minute versus −0.65 ± 0.37 net turns per minute for sham-infused mice; P < 0.001; Fig. 6d ). The uninternalized En2SR variant had no effect (data not shown), indicating that internalization of Engrailed is necessary for its protective and physiological effects. In conclusion, these results confirm that Engrailed, in addition to its survival effects, has a physiological function in dopaminergic activity.
Engrailed protects mDA neurons in other Parkinson models
Although MPTP intoxication is a widely used Parkinson's disease model 1 , we examined whether Engrailed could protect mDA neurons in two other models. We first used unilateral injection of 6-hydroxydopamine (6-OHDA) in the striatum, which provokes a Wallerian-like retrograde degeneration of the nigrostriatal dopamine pathway 15 leading to mDA cell death. 6-OHDA injection was followed 2 weeks later by the death of 60% of the mDA neurons in the SNpc, but the infusion of Engrailed in the midbrain reduced cell death to less than 20% (Fig. 7a) .
The second model is the injection into the SNpc of cell-permeable α-synuclein bearing an A30P mutation, a manipulation recently used to generate new rodent Parkinson's disease models on a relatively short time scale 16 . The in vitro toxicity of α-synuclein-A30P on midbrain neurons in culture was fully antagonized by the addition of En1 (data not shown). In vivo, the injection of the highly toxic α-synuclein-A30P mutant into the SNpc led to a 40% decrease in the number of tyrosine hydroxylase-positive cells after 2 weeks (Fig. 7b) . This cell death was fully antagonized by Engrailed infusion in the ventral midbrain immediately after α-synuclein-A30P injection (Fig. 7b) . Taken together, these observations demonstrate that Engrailed confers neuroprotection to mDA neurons in three established Parkinson's disease models. Figure 6 Engrailed-driven increases in striatal dopamine and turning behavior after MPTP are Ndufs1 dependent. (a) MPTP induced a 46% ± 2.3% (mean ± s.e.m.) decrease in striatal dopamine (DA) content compared to unlesioned mice. Engrailed infusion fully antagonized this decrease (115.25% ± 19.23%). Saline-injected control mice infused with Engrailed showed a 77.5% ± 20.42% increase in striatal dopamine compared to baseline (saline-infused mice and the uninfused contralateral side of the same mice). C, contralateral side; S, sham-infused; En, Engrailed-infused. *P < 0.05; # P < 0.05; n = 4-8. (b) In conditions where MPTP decreased DA 90%, Engrailed infusion increased DA by 3.5-fold (35% of salineinjected, sham-infused controls). Protection was fully blocked by the Ndufs1 siRNA but not by a control siRNA (saline-injected, sham-infused controls set as 100%, n = 5-7). (c) Engrailed induced significant contralateral turning in MPTP-intoxicated mice in the presence of a control siRNA. This behavior was fully antagonized when Engrailed was infused with Ndufs1 siRNA. Data expressed in net turns per minute. *P < 0.05, **P < 0.01; n = 5-10. (d) Engrailed significantly induced contralateral turning in unlesioned amphetamine-treated mice compared to sham-infused mice. ***P < 0.001; n = 17. Figure 7 Engrailed protects against 6-OHDA and α-synuclein-A30P toxicity. (a) 6-OHDA decreased the number of tyrosine hydroxylase-positive (TH + ) neurons by 59.35% ± 2.54% (mean ± s.e.m.; *P < 0.001) compared to that on the untreated side of each mouse. The infusion of En1 and En2 reduced cell loss to 17.81% ± 6.12% ( # P < 0.001). Data are expressed as percentage of control; n = 6-10 mice per group. S, sham-infused mice; En, Engrailed-infused mice. (b) Treatment with α-synuclein-A30P decreased the number of TH + neurons by 33.47% ± 9.93% (mean ± s.e.m.; *P = 0.005) compared to that on the untreated side, and infused En fully protected (compared to saline, # P < 0.001). No difference was detectable between the group treated with α-synuclein-A30P plus En and the control group (P = 0.46). Data are expressed in percentage of control; n = 4-6 mice per group. 23, 24 . We now report that exogenously applied Engrailed, which enters live cells, increases mitochondrial complex I activity and protects mDA neurons against MPP + and MPTP neurotoxicity in vitro and in vivo. This study also establishes a causal link between Engrailed-driven protection against MPP + /MPTP and the translation of complex I mitochondrial proteins, in particular Ndufs1. Local translation is an important physiological response to local cues and stimulation 11, 25 . Of particular relevance to this study is that Engrailed axon guidance activity requires its internalization and local protein translation 9, 10 . The present work raises the possibility that Engrailed locally regulates translation of mRNAs encoding mitochondrial proteins. In fact, given the many mitochondria present in synapses and growth cones, the finding that the translation of mitochondrial mRNAs is regulated locally is not surprising 26 .
Several observations suggest mitochondrial impairment in Parkinson's disease. First, complex I activity is reduced in the brains of people with this disease 3 . Second, MPTP in mice or nonhuman primates selectively kills mDA neurons through inhibition of complex I 1 . Third, genetic studies in familial forms of Parkinson implicate mitochondrial dysfunctions, as mutated nuclear genes encoding PINK1 (PTEN-induced putative kinase), Parkin (ubiquitin E3-protein ligase), α-synuclein, DJ-1 (a redox-sensitive chaperone) and LRRK2 (leucine-rich repeat kinase 2) all directly or indirectly affect mitochondrial physiology 27, 28 . This list underscores the importance of this organelle, and of complex I activity in Parkinson's disease.
Mammalian mitochondrial complex I is an assembly of 45 subunits, 7 of which are encoded by mitochondrial DNA and the remainder by the nuclear genome. Its catalytic core comprises 14 nuclearly encoded subunits; among these, Ndufs1 and Ndufs3 are key subunits for complex I assembly and activity 19, 29, 30 . The observation that Ndufs1 and Ndufs3 are specifically downregulated in mDA neurons in the SNpc of En1 +/− En2 +/+ mice strengthens the correlation between the mDA neuron degeneration observed in En1 +/− En2 +/+ mice 7 and a local decrease in Ndufs1 and Ndufs3. Ndufs1 is a particularly attractive Engrailed target since its cleavage by caspase-3 is at the origin of mitochondrial changes associated with cell death 19 . In this report, for practical reasons (siRNA design and controlled downregulation of Ndufs1 expression), we focused on siRNA-mediated Ndufs1 manipulation. This does not mean that other complex I subunits are not also downstream targets of the Engrailed survival pathway.
Given the importance of mitochondria and complex I activity in Parkinson's disease 1, 31 , protection of mDA neurons by Engrailed through translational regulation of complex I proteins suggests that Engrailed may be effective in several Parkinson's disease models. This was confirmed by the protective activity of Engrailed in the 6-OHDA and α-synuclein models. It is noteworthy that 6-OHDA induces a retrograde degeneration when injected into the striatum, a phenomenon taking place in Parkinson's disease 32 . The injection of toxic α-synuclein into the SNpc 16 is particularly pertinent because it mimics a mutation found in the human and takes advantage of the 'prion-like' character of the protein 33 . In our hands, the injection of the cell-permeable α-synuclein-A30P induced the death of 40% of the mDA cells in the SNpc after 2 weeks, and this toxicity was entirely blocked by Engrailed-1.
Other transcription factors important for mDA cell development are also expressed in adulthood and might contribute to Parkinson's disease. For instance, conditional knockout of Nurr1 in the adult leads to a slow and progressive loss of mDA neurons 34 . Similarly, Otx2 may function as a survival factor for mDA neurons in the VTA 35, 36 that are relatively spared in En1 +/− En2 +/+ mice and less dependent on En1 expression. One may imagine using exogenous Otx2 to rescue VTA mDA neurons, an approach validated in a mouse model of glaucoma 37, 38 .
Finally, Engrailed infused into the midbrain increases striatal dopamine, suggesting a physiological function in the regulation of nigrostriatal activity beyond neuroprotection. Indeed, the preferential turning toward the side contralateral to its infusion reflects this Engrailed-driven enhanced nigrostriatal function. It is of note that, similarly to the protective activity against MPTP toxicity, this function is abolished when Ndufs1 synthesis is inhibited, suggesting that several Engrailed functions in the mDA pathway involve its ability to regulate mitochondrial activity.
The notion that Engrailed is a regulator of mDA physiology in the adult allows one to consider homeoproteins from a nondevelopmental point of view. Given that En1 is detected in the dendrites of mDA neurons in vivo 14 , we propose that Engrailed in mDA dendrites acts to regulate local protein synthesis, in particular that of proteins participating in mitochondrial activity, in response to physiological stimulations.
In addition to Engrailed, other homeoproteins can regulate translation 9, 12, 39 , and the binding to eIF4E (eukaryotic initiation factor 4E) is a characteristic shared by many of them 39 . This raises the possibility that similar mechanisms involving other homeoproteins and other cell types could be involved in disorders associated with mitochondrial dysfunction. To further widen the context, an unsuspected role in the regulation of mitochondrial activity has recently been reported for other transcription factors that engage different mechanisms. It was shown, for instance, that Stat3, within mitochondria, interacts with complex I and complex II and regulates mitochondrial activity 40 . Similarly, MEF2D activates the transcription of ND6, a mitochondrially encoded complex I subunit 41 .
In conclusion, it is tempting to propose that the present findings, beyond their basic biological interest, open new therapeutic perspectives. It is in particular noteworthy that, were Engrailed to be considered as a putative therapeutic protein, it could not only protect neurons that otherwise would undergo degeneration but also increase the functional output of the remaining neurons.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/. siRnA coupling to Penetratin and testing in vivo. A predesigned siRNA against Ndufs1 (target sequence 5′-ATGCATGAAGATATTAATGAA-3′; Qiagen) or control siRNA with a thio-C6 linker modification on the 5′ end of the sense strand was incubated with an equimolar quantity of tris(2-carboxyethyl)phosphine hydrochloride (Sigma) before addition of activated Penetratin 1 (Q-Biogene) in twofold molar excess, and the mix was heated at 65 °C and further incubated at 37 °C before division into aliquots and freezing. For in vivo testing, a 1 µM solution of Penetratin-coupled Ndufs1 siRNA or control siRNA was infused in 8-week-old C57BL/6 mice as described above using 3-d micro-osmotic pumps. The ventral midbrain encompassing the SNpc was dissected 3 d after pump implantation and processed for western blot analysis.
western blot analysis. Western blot analyses were performed using standard procedures with the following primary antibodies: anti-Ndufs1 rabbit polyclonal (Proteintech), anti-Ndufs3 mouse monoclonal (Abcam), anti-COX IV rabbit polyclonal (Cell Signaling) and anti-actin goat polyclonal (Santa Cruz). The bands were quantified by densitometry.
HPlc. For dopamine measurements, striatal extracts were prepared and analyzed by HPLC using a reverse phase column (Nucleosil 120-3 C18; Knauer) and electrochemical detection as described 15 . Data were recorded and quantified using HPLC Chromeleon computer system (Dionex).
turning behavior. Amphetamine-induced rotation behavior was measured as previously described 49 . Mice received 5 mg kg −1 d-amphetamine hemisulfate salt (Sigma-Aldrich) and were placed after 20 min into individual glass bowls. Contralateral and ipsilateral turning were recorded for 5 min. Results are expressed as net turns per minute. Significant contralateral turning indicates an increase in nigrostriatal dopaminergic activity on the infused ipsilateral side 49, 50 .
Quantification of dAt activity. DAT activity was determined in cultured cells treated or not with Engrailed by measuring [ 3 H]dopamine uptake as described 45 .
Statistical analysis. Data are expressed as mean ± s.e.m. if not otherwise indicated. All in vitro experiments were performed at least in triplicate. Experimental data were compared by one-way ANOVA and a post hoc StudentNewman-Keuls test for pair-wise comparisons and post hoc Dunnett's test for comparisons to controls. P < 0.05 was considered significant.
